Skip to main content
. 2018 Apr 27;50(4):47. doi: 10.1038/s12276-018-0073-6

Fig. 1. Facilitation of 5-HT2AR-mediated arterial contractions by MK801 and ketamine.

Fig. 1

a Concentration-response curves (CRCs) of 5-HT-induced rat mesenteric arterial contractions in the absence and presence of MK801. b CRC of MK801-induced rat mesenteric arterial contractions in the presence of a physiological concentration (200 nM) of 5-HT. c CRC of (+) and (−) MK801-induced rat mesenteric arterial contractions in the presence of 200 nM of α-methyl 5-HT, a selective 5-HT2AR agonist. d Membrane potential (Em)-independent CRCs of 5-HT-induced rat mesenteric arterial contractions in the absence and presence of MK801 after pretreatment with 70 mM KCl and nifedipine (1 µM). e Em-independent CRCs of 5-HT-induced rat mesenteric arterial contractions in the absence and presence of ketamine after pretreatment with 70 mM KCl and nifedipine (1 µM). f CRC of MK801-induced rat mesenteric arterial contractions in the absence and presence of high (70 mM) KCl. g CRCs of phenylephrine-induced rat aorta contractions in the absence and presence of MK801. N in parentheses indicates the number of animals examined. *p < 0.05; **p < 0.01; N.S. not significant